News for Wockhardt Limited (WOCKPHARMA.BO)

The Nifty Bank index closed 0.3 per cent down at 56459.75.

The Nifty Auto index closed 0.19 per cent up at 23805.2.

Rekha Jhunjhunwalas March 2025 quarter stock additions outperformed the Sensex, with Nazara Technologies and Canara Bank delivering over 30% returns. Her portfolio reflects a diverse exposure across sectors, with 26 publicly held stocks worth over ₹41,570 crore.

Wockhardt is eyeing a huge opportunity in the US and European markets with its new antibiotic, Zaynich. Zaynich could address a $7 billion market in these regions. Wockhardt recently finished a key meeting with the US Food and Drug Administration (USFDA) in May 2025, which is a step before officially submitting its application. The company plans to file for USFDA approval in the second quarter of the current financial year, hoping to launch Zaynich in the US between April 2026 and March 2027.

Wockhardt's new antibiotic, Zaynich, targeting gram-negative infections, anticipates a significant USD 7 billion market in the US and Europe. Following a successful pre-NDA meeting with the USFDA, the company plans to file for approval this quarter, aiming for a launch in FY27.

Indian markets ended lower on Friday amid US tariff worries, dragging IT and auto stocks. Despite optimism around domestic GDP and FII inflows, Nifty showed weakness. Global cues remained mixed, while select stocks like BSE and Suzlon saw strong activity and interest.

Senores Pharmaceuticals is set to acquire Wockhardt's USFDA-approved ANDA for Topiramate tablets, a medication used for epilepsy and migraine treatment. This acquisition, valued at USD 111.47 million in the US market, will be funded from the proceeds of Senores' December IPO. Despite a strong market debut, the company's shares have since experienced a decline.

Key Results: Godrej Consumer Products, Bank of Baroda, CG Power & Industrial Solutions, HPCL, BSE, Polycab, One 97 Communications, Radico Khaitan, KEI Industries, Poly Medicure, Piramal Enterprises, Kansai Nerolac, Aadhar Housing Finance

Indian stock markets remained shut on Monday for Ambedkar Jayanti. Despite a late rebound on Friday following a 90-day U.S. tariff pause, benchmark indices ended the week 0.3% lower amid global trade uncertainty and cautious investor sentiment.

Metal stocks lead market rally, pharma, realty, IT also positive; Sensex up 2.12%, Nifty up 2.28%, 2402 stocks advance.

Drugmaker Wockhardt has decided to exit its remaining generics business in the US, for commercial reasons.

Despite market volatility, 56 stocks have retained multibagger status, delivering up to 760% returns since March 2024. Smallcaps like Ashika Credit Capital, Aayush Art, and Indo Thai Securities led gains, significantly outperforming the broader market, which returned only 1.6%.

Stocks including LIC, Bharat Electronics, Vedanta, Glenmark Pharma, Cipla, FirstCry, NHPC, VA Tech Wabag and more will be in the spotlight on Monday, February 10.

Stocks including Zomato, ITC, Bharti Airtel, Hero MotoCorp, Britannia, NTPC Green, Auro Pharma, BSE, Sobha, Solar Industries and more will be in the spotlight on Friday, February 07.

Buzzing Stocks Today, Stocks that will see action today: 7 February, 2025 - ITC, Agro Tech Foods, Fortis Healthcare, NTPC Green, Autobindo Pharma, Meson Valves, Solar Industries, Petront LNG, HG Infra, BSE, Zomato, Tata Power, Dr Reddy’s Lab, Mahindra Logistics, Asian Paints

The Nifty IT index was trading 0.67 per cent up at 42596.2.

Trent, Hero MotoCorp, Titan Company, Maruti Suzuki and Britannia were among the top losers on NSE.

The Nifty Bank index was trading 1.1 per cent up at 49753.0.

The Nifty Auto index was trading 0.33 per cent up at 23402.9.